AgomAb Therapeutics NV American Depositary Shares AGMB
Analyst Ratings
- Consensus
- Buy — 7 Buy · 0 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $37.50 (+333.5% upside)
Key Stats
- Today's Range
- $8.56 – $11.32
- 50-Day Range
- $8.56 – $16.50
- 52-Week Range
- $8.56 – $17.82
- Volume
- 639K shs
- Average Volume
- 177K shs
- Market Cap
- $425.99 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.24%
- Days to Cover
- 1.00
About AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Related Stocks
Compare head-to-head: AGMB vs NVDA·AGMB vs AAPL·AGMB vs GOOGL·AGMB vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.